GlassScriptPhysician profile
Dhirendra J Patel
NPI 1790773893
$792.83
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $769 · 2020: $23.85.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $252.48 | 2019 | |
| Merck Sharp & Dohme LLC | $96.95 | 2019 | |
| Janssen Biotech, INC. | $61.39 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $60.10 | 2019 | |
| Amag Pharmaceuticals, INC. | $56.19 | 2019 | |
| Amgen INC. | $42.12 | 2019 | |
| Foundation Medicine, INC. | $31.33 | 2019 | |
| Novartis Pharmaceuticals Corporation | $29.36 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $28.88 | 2019 | |
| Janssen Pharmaceuticals, INC | $27.27 | 2019 | |
| Avanir Pharmaceuticals, INC. | $23.85 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $20.72 | 2019 | |
| Celgene Corporation | $17.09 | 2019 | |
| Astellas Pharma US INC | $16.02 | 2019 | |
| Lilly USA, LLC | $14.96 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $14.12 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dhirendra Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.